Phoenix Biotech Acquisition Corp.
PBAX · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $7 | $0 | $0 |
| G&A Expenses | $9 | $3 | $0 |
| SG&A Expenses | $9 | $3 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 |
| Operating Expenses | $16 | $3 | $0 |
| Operating Income | -$16 | -$0 | -$0 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $5 | $0 | -$0 |
| Pre-Tax Income | -$11 | -$0 | -$0 |
| Tax Expense | $0 | $1 | -$0 |
| Net Income | -$11 | -$1 | -$0 |
| % Margin | – | – | – |
| EPS | -0.22 | -0.01 | -0.005 |
| % Growth | -2,122.2% | -115.2% | – |
| EPS Diluted | -0.22 | -0.01 | -0.005 |
| Weighted Avg Shares Out | 50 | 67 | 69 |
| Weighted Avg Shares Out Dil | 50 | 67 | 69 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $3 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | -$6 | $0 |
| EBITDA | -$16 | -$6 | -$0 |
| % Margin | – | – | – |